PRP Facial Rejuvenation

PRP (platelet-rich plasma) facial rejuvenation at Klinik Lautenschläger München uses the patient's own growth factor-rich blood concentrate to stimulate collagen production, accelerate skin renewal, and improve overall skin quality. A small venous blood draw is processed by centrifuge to produce concentrated plasma, which is then micro-injected into the dermis or applied topically following microneedling. PRP targets fine lines, skin laxity, dull complexion, and early acne scarring. Fully autologous — no synthetic materials — making it well-tolerated with minimal risk of adverse reaction.

Klinik Lautenschläger München offers platelet-rich plasma (PRP) facial rejuvenation as an autologous biological skin treatment, concentrating the patient's own growth factors to support tissue repair and collagen biosynthesis. The protocol begins with a small venous blood draw of 10–20 mL, collected into specialised tubes designed to maximise platelet recovery during centrifugation. The centrifuge separates the blood by density, isolating the platelet-concentrated plasma fraction at approximately three to five times the baseline platelet count found in whole blood. Platelets serve as the body's primary growth-factor reservoirs, releasing PDGF (platelet-derived growth factor), TGF-β (transforming growth factor beta), VEGF (vascular endothelial growth factor), IGF-1 (insulin-like growth factor), and EGF (epidermal growth factor) upon activation. When these growth factors are introduced into the dermis, they bind to receptors on local fibroblasts, keratinocytes, and endothelial cells, activating signal cascades that upregulate collagen and elastin synthesis, accelerate keratinocyte turnover, and stimulate new capillary formation. At Klinik Lautenschläger, PRP is delivered by micro-injection into the superficial and mid-dermis across the full face — a technique producing evenly distributed growth-factor distribution — or applied topically in conjunction with microneedling, where open micro-channels enable deep dermal penetration of the concentrate beyond what surface application achieves. Munich-based patients choose PRP at Klinik Lautenschläger for a range of concerns including progressive fine-line formation, skin laxity and loss of radiance, early acne scar remodelling, and post-summer pigmentation recovery following Alpine sun exposure. Because the treatment is entirely derived from the patient's own blood, there is no risk of allergic reaction or foreign-body response — a key advantage for patients sensitive to synthetic injectables. Results develop progressively over four to eight weeks as the growth-factor stimulus drives new tissue remodelling, with a series of two to three sessions recommended for optimal sustained outcomes.